|
Volumn 767, Issue 1, 2002, Pages 83-91
|
Development of a sensitive high-performance thin-layer chromatography method for estimation of ranitidine in urine and its application for bioequivalence decision for ranitidine tablet formulations
a a a a |
Author keywords
Bioequivalence; Ranitidine; Urinary excretion
|
Indexed keywords
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
PHARMACOKINETICS;
THIN LAYER CHROMATOGRAPHY;
HUMAN URINE;
DRUG PRODUCTS;
ACETIC ACID ETHYL ESTER;
AMMONIA;
DICHLOROMETHANE;
METHANOL;
RANITIDINE;
SILICA GEL;
ACCURACY;
ADULT;
ALKALINIZATION;
ARTICLE;
BIOAVAILABILITY;
BIOEQUIVALENCE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DRUG DETERMINATION;
DRUG FORMULATION;
DRUG ISOLATION;
HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY;
HUMAN;
HUMAN EXPERIMENT;
MALE;
NORMAL HUMAN;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
STATISTICAL ANALYSIS;
URINARY EXCRETION;
URINE;
AREA UNDER CURVE;
BIOLOGICAL AVAILABILITY;
CALIBRATION;
CHROMATOGRAPHY, THIN LAYER;
HISTAMINE H2 ANTAGONISTS;
HUMANS;
RANITIDINE;
REFERENCE VALUES;
REPRODUCIBILITY OF RESULTS;
SENSITIVITY AND SPECIFICITY;
THERAPEUTIC EQUIVALENCY;
|
EID: 0036162468
PISSN: 15700232
EISSN: None
Source Type: Journal
DOI: 10.1016/S0378-4347(01)00544-8 Document Type: Article |
Times cited : (17)
|
References (11)
|